The use of physostigmillc in the treatmcnt of tricyclic antideprcssant o7'crdost' is disclIsscd. The importance of cOlltilll/OIlS obst'r7'atioll is emplzasized ill/d the method of preparation of pizysostigminc is olltlil/ed. I "TI~() I) l' ('TIO); Drug ()verdo~age is a common caUSl' of hospital admissions and seems to he on the increase. Sedatives and tranquillizer~ arc ~till the Illust common drugs taken but the tricyclic antidepressanb arc close behind.
stimuli. :\n cndotracheal tube \\'as inserted, gastric lavage performed and ;")0 g of charcoal given via the gastric tube. Following this the patient was transferred to the Intensive Therapy {'nit with the endotracheal tube still in place, Ph\'sostigminc ~. 0 mg wa~ gin'n intravenously and the paticnt respondcd to light stimulation within :2-:) minutes. The patient was monitored and no dy,;rhythmias (including bradycardia) were seen at any stage after the physostigmine. Twent,' minutes later a further ~.() mg of physostigmine \\'as gin'n and \\'ithin two minutes the patient was ll1o\'ing about. One hour after the first dose of ph\'s()stigmine the patil'nt ('"tu bated herself. ('{(S( 2. . \ :! I-\Ta r-()]d female PS\T h iatric )la til'1l t was admitted foll()wing an oYl'rdosC' of trimipramine .iO mg (70 tablets), nitrazepalll ;i mg (::10 tablets) and lorazepam 1 mg (:!O tablets).
The patil'nt was responding to painful stimulus on admission to Accident and Emergencv Dcpa rtmcll t. (; astric la \'age \\'as P(,rf ornll'(i and ;iO g of charcoal gin'n \'ia the gastric tube. PII\'sostigmine :2·0 mg was then gi\'en intra-H'n<)l!sl\' following which the patient began to move her limbs and resjlond to shouted cOlllmands. A further 1 . () mg was given within twenty minutes and the patient startccl to speak. :\. further] . () mg of physostigmine was given three hours later as she was lapsing into unconsciousncss again. This produced an immediate response with the patient waking and asking for a drink. 1\'0 further ph~'sostig mine was required.
Case 3.
A 59-year-old female was admitted following ber third suicide attempt with an overdose of surmontil and serepax (trimipramine and ,·II/aestizesia al/d Il/tclIsiu Care, 1',,1, ]1', Xo. 2, Jla\', 11176 oxazepam). The amount taken was unknown. On admission she was semi-comatose and responded only to painful stimuli. The blood pressure was 160/90 and pulse rate 100 with occasional ventricular extrasystoles. Gastric lavage was performed and charcoal given via the stomach tube. She was given physostigmine 2·0 mg intravenously and she responded to shouted commands after ten minutes. The patient was transferred to the Intensive Therapy Unit for monitoring. Two and a half hours later a further 2·0 mg of physostigmine was given and the patient woke up, took out her oral airway and was rational and cooperative within two minutes. No further physostigmine was required and the patient was discharged home three days later.
Case 4.
A 17-year-old male was admitted following the ingestion of 42 tablets of amitriptyline 25 mg and 21 tablets of diazapam 5 mg some hours prior to admission.
On arrival his blood pressure was 110/90, pulse rate SO/minute and he responded only to painful stimuli. Gastric lavage was performed and charcoal given via the stomach tube. The patient was given 4 mg of physostigmine and became lighter within two minutes but went off to sleep again by 30 minutes. A further 6 mg of physostigmine was given in 2 mg increments and the patient woke up, removed his mask and airway, sat up and started talking within 10 minutes.
Three hours later it was necessary to give the patient a further 6 mg of physostigmine before he remained responsive. No bradycardia was detected after the 6 mg doses of physostigmine.
DISCUSSION
Two other anticholinesterase drugs, edrophonium and neostigmine were used on two other patients overdosed with tricyclic antidepressants but no change in level of consciousness was seen in either patient.
Of the common anticholinesterases, physostigmine is the only one that crosses the blood-brain barrier and it seems logical that this could be why it has its central anticholinesterase effect. It is rapidly metabolised and explains why repeated injections may be needed as in cases 2, 3 and 4. In none of the four patients was slowing of the pulse rate detected during the administration of physostigmine. Greene (1971) in his series of 31 patients to whom he gave physostigmine in the post-operative period showed only one case of slight bradycardia. All his doses of physostigmine were less than 1 ·5 mg.
Purging and the administration of charcoal is important, for agents such as the tricyclics which have significant anticholinergic activity diminish peristaltic activity of the bowel and thereby contribute to prolonged absorption (Goodman and Gillman 1970) .
Physostigmine injection is not commercially available in New Zealand and the solution was prepared in our hospital pharmacy.
Physostigmine is the main constituent alkaloid of the Calabar bean, the ripe seed of physostigma venenosum (Balfour), known also as Ordeal bean or Esere nut (hence the alternative name eserine). Physostigmine was the original anticholinesterase which for most purposes has been replaced by the synthetic drugs neostigmine, ambenonium, distigmine, edrephonium and pyridostigmine,. <1;11 of which have a less pronounced muscanmc activity. Physostigmine now is chiefly used in ophthalmology, mainly to reverse the effects of mydriatics. Solutions of the alkaloid are relatively unstable. However at a low pH, in the presence of a suitable antioxidant, protected from heat and light, quite reasonable stability can be obtained.
Ophthalmic preparations containing sodiu~ metabisulphite 0'05% as an antioxidant remam stable for up to six months at best and the fall in pH may lead to acidic irritation. The use of ascorbic acid as an antioxidant for solutions of physostigmine hydrobromide has been found to be superior to sodium metabisulphite. As an injection for intravenous use a low pH is no great problem in small volumes. A solution containing 0·2% ascorbic acid has a pH of 3 '75. For this reason ascorbic acid was employed as the antioxidant, serving also to maintain the pH at a suitable level.
Sterilization was performed by filtration using a Millipore Millex type S.L.G.S. membrane filter and the injection sealed into glass ampoules.
Formula: Physostigmine sulphate 2 mg
Acid ascorbic 2 mg Water for injection to 1 ml After six months at room temperature no signs of degradation of the physostigmine were present but the solution had assumed a pale brown colouration due to oxidation of the ascorbic acid. CONCLUSION Physostigminc seems to bc a signitlcant advance in the treatment of tricyclic overdose. Its early use will avoid many of the problems of central nervous system and respiratory depression.
Its use as an antidote to other sedatives and tranquillizers has been reported. Further clinical trials are indicated to evaluate its effectiveness.
